[HTML][HTML] Defining HLA-II ligand processing and binding rules with mass spectrometry enhances cancer epitope prediction

JG Abelin, D Harjanto, M Malloy, P Suri, T Colson… - Immunity, 2019 - cell.com
Increasing evidence indicates CD4+ T cells can recognize cancer-specific antigens and
control tumor growth. However, it remains difficult to predict the antigens that will be …

[HTML][HTML] Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction

JG Abelin, D Harjanto, M Malloy, P Suri, T Colson… - Immunity, 2019 - Elsevier
Increasing evidence indicates CD4+ T cells can recognize cancer-specific antigens and
control tumor growth. However, it remains difficult to predict the antigens that will be …

Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.

JG Abelin, D Harjanto, M Malloy, P Suri, T Colson… - Immunity, 2019 - europepmc.org
Increasing evidence indicates CD4+ T cells can recognize cancer-specific antigens and
control tumor growth. However, it remains difficult to predict the antigens that will be …

[HTML][HTML] Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction

JG Abelin, D Harjanto, M Malloy, P Suri, T Colson… - Immunity, 2019 - cell.com
Increasing evidence indicates CD4+ T cells can recognize cancer-specific antigens and
control tumor growth. However, it remains difficult to predict the antigens that will be …

[引用][C] Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction

JG Abelin, D Harjanto, M Malloy, P Suri, T Colson… - Immunity, 2019 - cir.nii.ac.jp
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances
Cancer Epitope Prediction | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction

JG Abelin, D Harjanto, M Malloy, P Suri… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Increasing evidence indicates CD4+ T cells can recognize cancer-specific antigens and
control tumor growth. However, it remains difficult to predict the antigens that will be …